Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
ContraFect (CFRXQ)
OTHER OTC:CFRXQ
Holding CFRXQ?
Track your performance easily
CFRXQ Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.04
Previous CloseN/A
Volume12.00K
Average Volume (3M)6.92K
Market Cap
$11.00
Enterprise ValueN/A
Total Cash (Recent Filing)$35.16M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta7.61
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-19.27
Shares Outstanding10,704,803
10 Day Avg. Volume153
30 Day Avg. Volume6,923
Standard Deviation12.80
R-Squared0.00076
Alpha1.44
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ownership Overview
―
Insiders
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
CFRXQ FAQ
What was ContraFect’s price range in the past 12 months?
ContraFect lowest stock price was <$0.01 and its highest was $0.04 in the past 12 months.
What is ContraFect’s market cap?
ContraFect’s market cap is $11.00.
When is ContraFect’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were ContraFect’s earnings last quarter?
Currently, no data Available
Is ContraFect overvalued?
According to Wall Street analysts ContraFect’s price is currently Overvalued.
Does ContraFect pay dividends?
ContraFect does not currently pay dividends.
What is ContraFect’s EPS estimate?
ContraFect’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ContraFect have?
ContraFect has 10,704,803 shares outstanding.
What happened to ContraFect’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of ContraFect?
Currently, no hedge funds are holding shares in CFRXQ
---
Company Description
ContraFect
ContraFect Corp. is a clinical stage biotechnology company , which engages in discovering and developing therapeutic protein and antibody products for the treatment of life-threatening infectious diseases. Its pipeline consists of CF-301, a bacteriophage-derived lysin with potent activity against Staphylococcus aureus bloodstream infections; and CF-404, which composed of three fully human monoclonal antibodies designed to treat all seasonal strains of human influenza. The company was founded by Robert Nowinski on March 5, 2008 and is headquartered in Yonkers, NY.
---
Atossa Therapeutics
―
ADMA Biologics
―
Akari Therapeutics
―
Vaxart
―
Zomedica Pharmaceuticals
―
---